Large genomic deletions in CACNA1A cause episodic ataxia type 2
Authors:
Open Access
- 1 January 2011
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 2, 11443
Abstract
Episodic ataxia (EA) syndromes are heritable diseases characterized by dramatic episodes of imbalance and incoordination. EA type 2 (EA2), the most common and the best characterized subtype, is caused by mostly nonsense, splice site, small indel, and sometimes missense mutations in CACNA1A. Direct sequencing of CACNA1A fails to identify mutations in some patients with EA2-like features, possibly due to incomplete interrogation of CACNA1A or defects in other EA genes not yet defined. Previous reports described genomic deletions between 4 and 40 kb in EA2. In 47 subjects with EA (26 with EA2-like features) who tested negative for mutations in the known EA genes, we used multiplex ligation-dependent probe amplification to analyze CACNA1A for exonic copy number variations. Breakpoints were further defined by long-range PCR. We identified distinct multi-exonic deletions in three probands with classic EA2-like features: episodes of prolonged vertigo and ataxia triggered by stress and fatigue, interictal nystagmus, with onset during infancy or early childhood. The breakpoints in all three probands are located in Alu sequences, indicating errors in homologous recombination of Alu sequences as the underlying mechanism. The smallest deletion spanned exons 39 and 40, while the largest deletion spanned 200 kb, missing all but the first three exons. One deletion involving exons 39 through 47 arose spontaneously. The search for mutations in CACNA1A appears most fruitful in EA patients with interictal nystagmus and onset early in life. The finding of large heterozygous deletions suggests haploinsufficiency as a possible pathomechanism of EA2.Keywords
This publication has 26 references indexed in Scilit:
- The Therapeutic Mode of Action of 4-Aminopyridine in Cerebellar AtaxiaThe Journal of Neuroscience, 2010
- The impact of retrotransposons on human genome evolutionNature Reviews Genetics, 2009
- Late-onset episodic ataxia type 2 associated with a novel loss-of-function mutation in the CACNA1A geneJournal of the Neurological Sciences, 2009
- Episodic ataxia: SLC1A3 and CACNB4 do not explain the apparent genetic heterogeneityJournal of Neurology, 2008
- Primary episodic ataxias: diagnosis, pathogenesis and treatmentBrain, 2007
- Dominant-negative effects of human P/Q-type Ca2+ channel mutations associated with episodic ataxia type 2American Journal of Physiology-Cell Physiology, 2006
- Late-onset episodic ataxia type 2 due to an in-frame insertion in CACNA1ANeurology, 2005
- Clinical spectrum of episodic ataxia type 2Neurology, 2004
- High prevalence of CACNA1A truncations and broader clinical spectrum in episodic ataxia type 2Neurology, 1999
- Hereditary paroxysmal ataxiaNeurology, 1978